Skip to main content
OpenTrials
Completed

NCT Number: NCT07263737

Pulsed Electromagnetic Field Therapy for Neuropathic Pain in Lumbar Disc Herniation

This randomized controlled study evaluated whether adding pulsed electromagnetic field (PEMF) therapy to conventional physical therapy provides additional benefits for neuropathic pain and disability in patients with lumbar disc herniation (LDH).

→ This study randomly assigned patients into groups to compare treatments. It examined whether adding pulsed electromagnetic field (PEMF) therapy to standard physical therapy could give extra improvement in nerve-related pain and daily function in people with a slipped disc in the lower back.

Fifty-two patients with ≥3 months of radicular and neuropathic symptoms were enrolled and randomly assigned to a treatment group (PEMF + conventional therapy) or a control group (sham PEMF + conventional therapy).

→ Fifty-two patients who had leg pain and nerve-related symptoms for at least three months joined the study. They were randomly placed into either a treatment group (which received PEMF plus regular therapy) or a control group (which received a fake PEMF treatment plus regular therapy).

Both groups received transcutaneous electrical nerve stimulation, hot packs, and a lumbar exercise program for 15 sessions.

→ Both groups also received the same standard treatments: electrical nerve stimulation, hot packs, and a lower-back exercise program for 15 sessions.

Clinical outcomes-including Visual Analog Scale (VAS), pressure pain threshold, Modified Schober test, DN4, PainDetect, Oswestry Disability Index (ODI), and SF-36-were assessed at baseline, post-treatment, and one month after treatment.

→ Several health measures were checked before treatment, right after treatment, and again one month later. These included pain level (VAS), how sensitive the area was to pressure, lower-back flexibility, nerve-pain questionnaires (DN4 and PainDetect), disability level (ODI), and overall quality of life (SF-36).

Forty-six patients completed the study. → A total of 46 patients finished the study.

Both groups showed significant improvements in VAS scores, neuropathic pain questionnaires (DN4, PainDetect), ODI, and several SF-36 subscales (physical functioning, role-physical, and pain), with additional improvements in emotional role and social functioning observed only in the PEMF group.

→ Both groups improved in many areas: pain levels, nerve-pain scores, disability, and some parts of quality of life (such as physical functioning, daily roles, and pain). Only the PEMF group showed extra improvement in emotional well-being and social activities.

However, none of the between-group comparisons demonstrated significant differences.

* However, when the two groups were compared to each other, there were no meaningful differences.

No meaningful changes were found in lumbar flexibility or pressure pain thresholds in either group.

→ Neither group showed important changes in lower-back flexibility or in how much pressure they could tolerate on painful areas.

In conclusion, adding PEMF therapy to conventional physical therapy did not provide additional benefit for neuropathic symptoms, radicular pain, disability, lumbar flexibility, pressure pain threshold, or quality of life in patients with LDH-related neuropathic pain.

→ In summary, adding PEMF therapy to regular physical therapy did not give extra benefits for nerve pain, leg pain, disability, back flexibility, sensitivity to pressure, or quality of life in people with nerve-related pain caused by a slipped disc.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Haydarpasa Numune Training and Research Hospital Physical Rehabilitation and Medicine Clinic

Istanbul, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Radicular pain and neuropathic symptoms lasting longer than 3 months
  • Presence of lumbar disc herniation on lumbar MRI
  • Age between 18 and 75 years
  • Visual Analog Scale (VAS) ≥ 4
  • DN4 ≥ 4
  • At least one positive test among Straight Leg Raise Test (SLRT) and femoral stretch test
  • Patients without cognitive impairment who are able to follow verbal instructions

Exclusion criteria

-• Having undergone an interventional lumbar injection within the last 3 months

  • Receiving physical therapy within the last 3 months
  • Using medical treatment for neuropathic pain within the last 3 months
  • History of lumbar surgery
  • Presence of another neurological disorder that could cause neuropathic symptoms
  • Cauda equina syndrome
  • History of malignancy
  • Uncontrolled cardiopulmonary disease
  • Pregnancy
  • Presence of a pacemaker or electronic implant
  • Presence of diabetic neuropathy

Treatment and study plan

Pulsed electromagnetic field (PEMF)

Device

In our study, the device used for PEMA application was the BTL-4000 Smart. The PEMA waves applied to the treatment group were elongated square-wave signals with a frequency of 55.55 Hz and a magnetic flux density of 30 mT. A 60-cm solenoid applicator of the device was used. With this applicator, a 30-minute treatment was delivered to cover the lumbar region.

Sham PEMF

Device

Sham application with the same device

Primary outcomes

  1. VAS

    Time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

    Visual Analog Scale (VAS): VAS is the most frequently used parameter for measuring pain intensity in low back pain studies. It is a self-reported scale that typically consists of a 10-cm horizontal or vertical line with two verbal descriptors placed at each end to indicate the extremes of pain. Patients are asked to mark the point that best represents their pain. The VAS score is obtained by measuring the distance in centimeters from the starting point to the patient's mark. In our study, VAS was used to assess the pain experienced by patients in the low back and leg regions during the previous week. VAS was evaluated in three different conditions: at rest, during movement, and at night.

  2. PPT

    Time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

    Pressure Pain Threshold (PPT) Measurements with an Algometer:

    An algometer is a pressure-measuring device with a 1-cm rounded tip. The sensation of pressure and pain occurs when polymodal nociceptive nerve endings in superficial and deep tissues are stimulated. Algometers are used in clinical studies to measure the pressure pain threshold.

    After the measurement points are identified, the rounded tip of the device is placed perpendicular to the surface of the body being examined. Pressure is increased continuously at a rate of approximately 1 kg per second. Patients are instructed to indicate the moment they first feel any pain or discomfort. As soon as they report this sensation, the pressure is stopped and the pressure pain threshold value is read from the device .

    In our study, PPTmeasurements obtained with an algometer were used to evaluate the patients' pain sensitivity. The Jtech Commander Algometer was used as the device.

Secondary outcomes

  1. Neuropathic pain

    Time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

    DN4 and PainDetect Questionnaire (PDQ)

  2. Physical examination tests

    Time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

    Straight Leg Raise Test (SLRT), femoral stretch test, and the Modified Schober test

  3. Disability

    Time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

    Oswestry Disability Index (ODI)

  4. Quality of life Short Form-36 (SF-36) questionnaire

    Time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

    The SF-36 questionnaire was developed by Ware as a general assessment tool intended for use in many diseases, evaluating quality of life through physical and mental health parameters.

Sponsors and collaborators

Lead sponsor

Haydarpasa Numune Training and Research Hospital

Other

Registry information

Official study title

Effectiveness of Pulsed Electromagnetic Field Therapy on Neuropathic Pain and Disability in Patients With Lumbar Disc Herniation: A Randomized, Double-Blind, Placebo-Controlled Trial

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Dec 4, 2025
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.